158 related articles for article (PubMed ID: 31809044)
21. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
22. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
23. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
24. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B.
Li C; Baquiran G; Gu F; Tremblay ML; Fazel A; Bergeron JJ; Posner BI
Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466
[TBL] [Abstract][Full Text] [Related]
25. Covalent inhibition of protein tyrosine phosphatases.
Ruddraraju KV; Zhang ZY
Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of the LAR protein tyrosine phosphatase receptor is associated with increased dentate gyrus neurogenesis and an increased number of granule cell layer neurons.
Bernabeu R; Yang T; Xie Y; Mehta B; Ma SY; Longo FM
Mol Cell Neurosci; 2006 Apr; 31(4):723-38. PubMed ID: 16488625
[TBL] [Abstract][Full Text] [Related]
27. Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases.
Chagnon MJ; Uetani N; Tremblay ML
Biochem Cell Biol; 2004 Dec; 82(6):664-75. PubMed ID: 15674434
[TBL] [Abstract][Full Text] [Related]
28. A unique and rapid approach toward the efficient development of novel protein tyrosine phosphatase (PTP) inhibitors based on 'clicked' pseudo-glycopeptides.
Yang JW; He XP; Li C; Gao LX; Sheng L; Xie J; Shi XX; Tang Y; Li J; Chen GR
Bioorg Med Chem Lett; 2011 Feb; 21(4):1092-6. PubMed ID: 21251827
[TBL] [Abstract][Full Text] [Related]
29. Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. elegans.
Mitchell CJ; Kim MS; Zhong J; Nirujogi RS; Bose AK; Pandey A
Mol Oncol; 2016 Jun; 10(6):910-20. PubMed ID: 27067626
[TBL] [Abstract][Full Text] [Related]
30. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
31. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
32. Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase.
Ge L; Li KS; Li MM; Xiao P; Hou XB; Chen X; Liu HD; Lin A; Yu X; Ren GJ; Fang H; Sun JP
Bioorg Med Chem Lett; 2016 Oct; 26(19):4795-4798. PubMed ID: 27554446
[TBL] [Abstract][Full Text] [Related]
33. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing.
Ruhe JE; Streit S; Hart S; Ullrich A
Cell Signal; 2006 Sep; 18(9):1515-27. PubMed ID: 16478662
[TBL] [Abstract][Full Text] [Related]
34. Alendronate inhibition of protein-tyrosine-phosphatase-meg1.
Opas EE; Rutledge SJ; Golub E; Stern A; Zimolo Z; Rodan GA; Schmidt A
Biochem Pharmacol; 1997 Sep; 54(6):721-7. PubMed ID: 9310349
[TBL] [Abstract][Full Text] [Related]
35. Natural products with protein tyrosine phosphatase inhibitory activity.
Carr G; Berrue F; Klaiklay S; Pelletier I; Landry M; Kerr RG
Methods; 2014 Jan; 65(2):229-38. PubMed ID: 24056213
[TBL] [Abstract][Full Text] [Related]
36. Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth.
Yang T; Yin W; Derevyanny VD; Moore LA; Longo FM
Eur J Neurosci; 2005 Nov; 22(9):2159-70. PubMed ID: 16262654
[TBL] [Abstract][Full Text] [Related]
37. Leukocyte antigen-related protein tyrosine phosphatase receptor: a small ectodomain isoform functions as a homophilic ligand and promotes neurite outgrowth.
Yang T; Bernabeu R; Xie Y; Zhang JS; Massa SM; Rempel HC; Longo FM
J Neurosci; 2003 Apr; 23(8):3353-63. PubMed ID: 12716943
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate.
Heo YS; Ryu JM; Park SM; Park JH; Lee HC; Hwang KY; Kim J
Exp Mol Med; 2002 Jul; 34(3):211-23. PubMed ID: 12216113
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in protein tyrosine phosphatase detection using chemical probes.
Lee K; Kang HJ; Xia Y; Chung SJ
Anticancer Agents Med Chem; 2011 Jan; 11(1):54-63. PubMed ID: 21235434
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein tyrosine phosphatase non-receptor type 2 by PTP inhibitor XIX: Its role as a multiphosphatase inhibitor.
Le HTT; Cho YC; Cho S
BMB Rep; 2017 Jun; 50(6):329-334. PubMed ID: 28228214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
